Literature DB >> 19328415

Toward better models of hyperthyroid Graves' disease.

Selçuk Dağdelen1, Yi-chi M Kong, J Paul Banga.   

Abstract

Graves' disease affects only humans. Although it is a treatable illness, medical therapy with antithyroid drugs is imperfect, showing high rates of recurrence. Furthermore, the etiology and treatment of the associated ophthalmopathy still represent problematic issues. Animal models could contribute to the solution of such problems by providing a better understanding of the underlying pathogenesis and could be used for evaluating novel therapeutic strategies. This article discusses the pursuit of a better experimental model for hyperthyroid Graves' disease and outlines how this research has clarified the immunology of the disease.

Entities:  

Mesh:

Year:  2009        PMID: 19328415     DOI: 10.1016/j.ecl.2009.01.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA.

Authors:  Shuang-Xia Zhao; Shanli Tsui; Anthony Cheung; Raymond S Douglas; Terry J Smith; J Paul Banga
Journal:  J Endocrinol       Date:  2011-06-29       Impact factor: 4.286

2.  Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.

Authors:  Nan Xia; Xiaozhen Ye; Xiaohao Hu; Shiyu Song; Hui Xu; Mengyuan Niu; Hongwei Wang; Jian Wang
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

3.  Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation.

Authors:  Dhanesh Amarnani; Angie V Sanchez; Lindsay L Wong; Brandon V Duffy; Leslie Ramos; Suzanne K Freitag; Diane R Bielenberg; Leo A Kim; Nahyoung Grace Lee
Journal:  Transl Vis Sci Technol       Date:  2020-07-16       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.